Literature DB >> 36212266

PATHOLOGICALLY-CONFIRMED ISOLATED HYPOTHALAMO-PITUITARY SARCOIDOSIS REFRACTORY TO PULSE-DOSE GLUCOCORTICOIDS AND SUCCESSFULLY TREATED WITH METHOTREXATE.

B Borawski1, P Kuca1, G Zieliński2, M Maksymowicz3, P Witek1.   

Abstract

Isolated sarcoidosis of the hypothalamic-pituitary system is a very rare form of neurosarcoidosis. A high index of suspicion is required for diagnosis and the choice of therapy embodies another challenge due to lack of standardized protocols. Glucocorticoids are the mainstay of initial treatment, whereas the second and third-line therapy include immunomodulators and cytotoxic drugs, in addition to monoclonal antibodies. This report presents an unusual case of panhypopituitarism in a 32-year-old previously healthy male patient due to isolated hypothalamo-pituitary sarcoidosis confirmed histologically, refractory to pulse-dose glucocorticoids and then successfully treated by methotrexate. Based on our report, in patients requiring additional therapy usage of the methotrexate as the second line agent should be considered, however the time frame and the dosing schedule of methotrexate are still unknown and deserve further investigation. ©2022 Acta Endocrinologica (Buc).

Entities:  

Keywords:  Sarcoidosis; hypothalamus; isolated; methotrexate; neurosarcoidosis; pituitary

Year:  2022        PMID: 36212266      PMCID: PMC9512385          DOI: 10.4183/aeb.2022.244

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  16 in total

1.  18F-FDG Uptake in Neurosarcoid Dural Plaque on PET/CT.

Authors:  Iman Khodarahmi; Roger E Turbin; Larry P Frohman; Nasrin Ghesani
Journal:  Clin Nucl Med       Date:  2016-09       Impact factor: 7.794

Review 2.  Magnetic resonance imaging and symptoms in patients with neurosarcoidosis and central diabetes insipidus.

Authors:  Eiichi Kakehi; Seiji Adachi; Yusuke Fukuyasu; Yasuhiro Hashimoto; Shigehisa Sakurai; Akane Hirotani; Hisanori Danbara; Kaduyo Shimizu; Ryosuke Fujita; Hiroyuki Teraura; Kazuhiko Kotani; Masami Matsumura
Journal:  Endokrynol Pol       Date:  2019       Impact factor: 1.582

Review 3.  Inflammatory Manifestations of Systemic Diseases in the Central Nervous System.

Authors:  David A Lapides; Mark M McDonald
Journal:  Curr Treat Options Neurol       Date:  2020-07-29       Impact factor: 3.598

Review 4.  Hypothalamic-pituitary sarcoidosis with vision loss and hypopituitarism: case series and literature review.

Authors:  Jeremy Anthony; Gregory J Esper; Adriana Ioachimescu
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

5.  Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group.

Authors:  Barney J Stern; Walter Royal; Jeffrey M Gelfand; David B Clifford; Jinny Tavee; Siddharama Pawate; Joseph R Berger; Allen J Aksamit; Allan Krumholz; Carlos A Pardo; David R Moller; Marc A Judson; Marjolein Drent; Robert P Baughman
Journal:  JAMA Neurol       Date:  2018-12-01       Impact factor: 18.302

Review 6.  Overview of neurosarcoidosis: recent advances.

Authors:  Renata Hebel; Mirosława Dubaniewicz-Wybieralska; Anna Dubaniewicz
Journal:  J Neurol       Date:  2014-09-07       Impact factor: 4.849

Review 7.  Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis.

Authors:  Daan Fritz; Diederik van de Beek; Matthijs C Brouwer
Journal:  BMC Neurol       Date:  2016-11-15       Impact factor: 2.474

Review 8.  Management of neurosarcoidosis: a clinical challenge.

Authors:  Mareye Voortman; Marjolein Drent; Robert P Baughman
Journal:  Curr Opin Neurol       Date:  2019-06       Impact factor: 5.710

9.  Infliximab treatment in pathology-confirmed neurosarcoidosis.

Authors:  Daan Fritz; Wilhelmina M C Timmermans; Jan A M van Laar; P Martin van Hagen; Theodora A M Siepman; Diederik van de Beek; Matthijs C Brouwer
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-07-27

Review 10.  Hypothalamic-Pituitary Axis Dysfunction, Central Diabetes Insipidus, and Syndrome of Inappropriate Antidiuretic Hormone Secretion as the First Clinical Presentation of Neurosarcoidosis: Why Early Diagnosis and Treatment is Important?

Authors:  Tatjana Blazin; Dhruvil Prajapati; Linha Lina M Mohammed; Meera Dhavale; Mohamed K Abdelaal; A B M Nasibul Alam; Natalia P Ballestas; Jihan A Mostafa
Journal:  Cureus       Date:  2020-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.